Grantham, Mayo, Van Otterloo & Co (GMO)’s Matsons MATX Stock Holding History
Bought
Maintained
Sold
Other funds holding MATX
Grantham, Mayo, Van Otterloo & Co (GMO)'s MATX Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Matsons (MATX) stake by 14% in Q2 2026, selling an estimated $149K and leaving 5,012 shares worth $963K. The position accounts for ﹤0.01% of the portfolio, ranked #524.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MATX in Q1 2016 and has held it in 21 quarters since. The position peaked at $4.25M in Q2 2016. 428 funds tracked by Wall St. Rank hold MATX as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 5,012 shares of Matsons worth $963K as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 819 Matsons shares in Q2 2026, an estimated $149K.
- Matsons made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #524 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Matsons in Q1 2016 and has held it in 21 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Matsons position peaked at $4.25M in Q2 2016.
- 428 funds tracked by Wall St. Rank held Matsons as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.